X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-03 | GLTO | Winslow Garrett | GC | S - Sale+OE | $5.60 | -471 | 1,009 | -32% | -$2,638 | |||||
| D | 2025-01-03 | GLTO | Firmani Lori | Interim CFO | S - Sale+OE | $5.63 | -261 | 465 | -36% | -$1,469 | |||||
| D | 2025-01-03 | GLTO | Schambye Hans T. | CEO | S - Sale+OE | $5.60 | -1,341 | 3,397 | -28% | -$7,510 | |||||
2023-08-15 | GLTO | Orbimed Advisors LLC | 10% | S - Sale | $0.75 | -822,680 | 1,510,375 | -35% | -$617,010 | ||||||
2023-07-31 | GLTO | Orbimed Advisors LLC | 10% | S - Sale | $3.00 | -209,400 | 2,105,909 | -9% | -$628,200 | ||||||
2023-07-25 | GLTO | Orbimed Advisors LLC | 10% | S - Sale | $2.92 | -39,200 | 2,258,987 | -2% | -$114,464 | ||||||
2023-07-13 | GLTO | Orbimed Advisors LLC | 10% | S - Sale | $2.40 | -194,700 | 2,285,687 | -8% | -$467,280 | ||||||
| M | 2023-04-13 | GLTO | Orbimed Advisors LLC | 10% | S - Sale | $1.87 | -68,481 | 2,417,787 | -3% | -$128,257 | |||||
| M | 2023-04-10 | GLTO | Orbimed Advisors LLC | 10% | S - Sale | $1.80 | -67,537 | 2,464,234 | -3% | -$121,357 | |||||
| M | 2023-04-05 | GLTO | Orbimed Advisors LLC | 10% | S - Sale | $2.16 | -102,630 | 2,510,041 | -4% | -$221,994 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |